Senti Biosciences Holdings, Inc.
NASDAQSenti Biosciences heads into its May 6 earnings call with short sellers piling in at a pace not seen in months — and a fresh $40 million financing deal raising its own questions about dilution. The short interest story this week is hard to ignore. At 4.7% of free float, the position itself is not extreme. But the pace of accumulation is: short interest more than doubled over the…
Short interest % of float, cost to borrow, utilization, and put/call ratio for SNTI are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
Snapshot as of 6 May 2026
Senti Biosciences heads into its May 6 earnings call with short sellers piling in at a pace not seen in months — and a fresh $40 million financing deal raising its own questions about dilution. The short interest story…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SNTI — free to start on ORTEX.
Sign up for free →Open SNTI on ORTEX